| 1 |
Aubert O, Yoo D, Zielinski D, et al. COVID-19 pandemic and worldwide organ transplantation: a population-based study[J]. Lancet Public Health, 2021, 6(10): e709-e719.
|
| 2 |
国务院应对新型冠状病毒肺炎疫情联防联控机制综合组. 关于对新型冠状病毒感染实施"乙类乙管"的总体方案[EB/OL]. (2022-12-07)[2023-01-05].
URL
|
| 3 |
Peghin M, Grossi PA. COVID-19 positive donor for solid organ transplantation[J]. J Hepatol, 2022, 77(4): 1198-1204.
|
| 4 |
Bock MJ, Vaughn GR, Chau P, et al. Organ transplantation using COVID-19-positive deceased donors[J]. Am J Transplant, 2022, 22(9): 2203-2216.
|
| 5 |
Dhand A, Okumura K, Nabors C, et al. Solid organ transplantation from COVID positive donors in the United States: analysis of United Network for Organ Sharing Database[J]. Transpl Infect Dis, 2022: e13925.
|
| 6 |
国家卫生健康委办公厅，中央军委后勤保障部卫生局. 血站新冠病毒感染防控工作指引(第二版) [EB/OL]. (2022-12-17)[2023-01-05].
URL
|
| 7 |
中华医学会器官移植学分会，中国医师协会器官移植医师分会，国家人体捐献器官获取质量控制中心. 新型冠状病毒感染者器官捐献专家共识[J]. 器官移植，2023, 14(1): 1-10.
|
| 8 |
Brogan M, Ross MJ. COVID-19 and kidney disease[J]. Annu Rev Med, 2023, 74：1-13.
|
| 9 |
Pacheco ICR, Costa D, Sousa DS, et al. Kidney injury associated with COVID-19 infection and vaccine: a narrative review [J]. Front Med (Lausanne), 2022, 9: 956158.
|
| 10 |
Menez S, Parikh CR. COVID-19 and the kidney: recent advances and controversies[J]. Seminars in nephrology, 2022, 42(3): 151279.
|
| 11 |
Yang Y, Zou S, Xu G. An update on the interaction between COVID-19, vaccines, and diabetic kidney disease[J]. Front Immunol, 2022, 13: 999534.
|
| 12 |
Silva-Aguiar RP, Teixeira DE, Peres RaS, et al. Subclinical acute kidney injury in COVID-19: possible mechanisms and future perspectives[J]. Int J Mol Sci, 2022, 23(22): 14193.
|
| 13 |
Nogueira GM, Silva N, Moura AF, et al. Acute kidney injury and electrolyte disorders in COVID-19[J]. World J Virol, 2022, 11(5): 283-292.
|
| 14 |
Stein SR, Ramelli SC, Grazioli A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy[J]. Nature, 2022, 612(7941): 758-763.
|
| 15 |
Braun F, Lütgehetmann M, Pfefferle S, et al. SARS-CoV-2 renal tropism associates with acute kidney injury[J]. Lancet, 2020, 396(10251): 597-598.
|
| 16 |
Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection[J]. Nat Commun, 2021, 12(1): 2506.
|
| 17 |
Golmai P, Larsen CP, Devita MV, et al. Histopathologic and ultrastructural findings in postmortem kidney biopsy material in 12 patients with AKI and COVID-19[J]. J Am Soc Nephrol, 2020, 31(9): 1944-1947.
|
| 18 |
Sharma P, Uppal NN, Wanchoo R, et al. COVID-19-associated kidney injury: a case series of kidney biopsy findings[J]. J Am Soc Nephrol, 2020, 31(9): 1948-1958.
|
| 19 |
Wang L, Li X, Chen H, et al. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China[J]. Am J Nephrol, 2020, 51(5): 343-348.
|
| 20 |
Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens[J]. Jama, 2020, 323(18): 1843-1844.
|
| 21 |
林俊，丁小明，朱一辰，等. 肾移植受者新型冠状病毒疫苗接种建议[J] . 中华器官移植杂志，2022, 43(2)：67-73.
|
| 22 |
Li L, Chen X, Li B, et al. Effect of inactivated SARS-CoV-2 vaccine on thyroid function and autoimmunity within 28 days after the second dose [J]. Thyroid, 2022, 32(9): 1051-1058.
|
| 23 |
Xiong X, Wong CKH, Au ICH, et al. Safety of inactivated and mRNA COVID-19 vaccination among patients treated for hypothyroidism: a population-based cohort study[J]. Thyroid, 2022, 32(5): 505-514.
|
| 24 |
崔瑜，张雷，，吴建永. 肾移植抗体介导排斥反应的预防及诊疗要点[J]. 中华医学杂志，2022, 102(26)：2041-2044.
|
| 25 |
Ramalhete LM, Araújo R, Ferreira A, et al. Proteomics for biomarker discovery for diagnosis and prognosis of kidney transplantation rejection[J]. Proteomes, 2022, 10(3)：24.
|
| 26 |
Nakorchevsky A, Hewel JA, Kurian SM, et al. Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies[J]. J Am Soc Nephrol, 2010, 21(2): 362-373.
|
| 27 |
Lin XC, Sui WG, Qi SW, et al. Quantitative proteomic profiling of renal tissue in human chronic rejection biopsy samples after renal transplantation[J]. Transplant Proc, 2015, 47(2): 323-331.
|
| 28 |
Paşatu-Cornea AM, Ciciu E, Tuţǎ LA. Perforin: an intriguing protein in allograft rejection immunology (Review) [J]. Exp Ther Med, 2022, 24(2): 519.
|
| 29 |
Loga L, Dican L, Matei HV, et al. Relevant biomarkers of kidney allograft rejection[J]. J Med Life, 2022, 15(11): 1330-1333.
|
| 30 |
Dhrolia M, Ahmad A. Development of Banff Classification from 1991 to 2019 for identifying renal allograft rejection: a narrative review for nephrologists[J]. J Pak Med Assoc, 2022, 72(8)：1615-1621.
|
| 31 |
Ho J, Rush DN, Krokhin O, et al. Elevated urinary matrix metalloproteinase-7 detects underlying renal allograft inflammation and injury[J]. Transplantation, 2016, 100(3): 648-654.
|
| 32 |
Heidari SS, Nafar M, Kalantari S, et al. Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: a urinary proteomics analysis[J]. J Proteomics, 2021, 240: 104208.
|
| 33 |
Sui W, Huang L, Dai Y, et al. Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS[J]. Clin Exp Med, 2010, 10(4): 259-268.
|
| 34 |
Yeo WS, Ng QX. Biomarkers of immune tolerance in kidney transplantation: an overview [J]. Pediatr Nephrol, 2022, 37(3): 489-498.
|
| 35 |
Braud C, Baeten D, Giral M, et al. Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis[J]. J Cell Biochem, 2008, 103(6): 1681-1692.
|
| 36 |
Brouard S, Mansfield E, Braud C, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance[J]. Proc Natl Acad Sci U S A, 2007, 104(39): 15448-15453.
|
| 37 |
Torrico S, Hotter G, Játiva S. Development of cell therapies for renal disease and regenerative medicine[J]. Int J Mol Sci, 2022, 23(24): 15943.
|
| 38 |
Bednar KJ, Lee JH, Ort T. Tregs in autoimmunity: Insights into intrinsic brake mechanism driving pathogenesis and immune homeostasis[J]. Front Immunol, 2022, 13: 932485.
|
| 39 |
Qu G, Chen J, Li Y, et al. Current status and perspectives of regulatory T cell-based therapy [J]. J Genet Genomics, 2022, 49(7): 599-611.
|
| 40 |
Petrosyan A, Montali F, Peloso A, et al. Regenerative medicine technologies applied to transplant medicine. An update [J]. Front Bioeng Biotechnol, 2022, 10: 1015628.
|
| 41 |
Matsuzaka Y, Yashiro R. Therapeutic strategy of mesenchymal-stem-cell-derived extracellular vesicles as regenerative medicine[J]. Int J Mol Sci, 2022, 23(12)：6480.
|
| 42 |
García-Perdomo HA, Jurado-Penagos A. Application of regenerative medicine and 3d bioprinting in urology[J]. Actas urologicas espanolas, 2022, 46(6): 323-328.
|
| 43 |
Bejoy J, Qian ES, Woodard LE. Tissue culture models of AKI: from tubule cells to human kidney organoids[J]. J Am Soc Nephrol, 2022, 33(3): 487-501.
|